Now showing items 1-1 of 1
A review on potential of PARP inhibitors in the treatment of prostate cancer
(Brac University, 2022-05)
Prostate cancer is still a fatal disease at metastatic castration resistance stage (mCRPC) in spite of pursuing advancements in patient survival, indicating the necessity of therapeutic approaches. A significant number of ...